TABLE 3.
Cross-resistance of 94 clinical HIV-1 isolates between efavirenz and VRX-480773
Efavirenz fold change in EC50 value | No. (%) of isolates with VRX-480773 fold change in EC50 value ofa:
|
|
---|---|---|
<10 | >10 | |
<10 | 24 (22.4) | 3 (0.9) |
>10 | 28 (45.9) | 39 (19.1) |
Numbers in parentheses correspond to the percentage of total isolates in the Stanford database.